Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Study 3: Chronic care management
BRIGHT MINDS BIOSCIENCES INC.
Smoking, Tobacco
1 trial -
Sublingual film containing Dexmedetomidine
BioXcel Therapeutics
Agitation,Psychomotor
1 trial -
Suboxone Remote Observed Dosing
BRIGHT MINDS BIOSCIENCES INC.
Opioid-use Disorder
1 trial -
Sugammadex Injection 2mg/kg
BRIGHT MINDS BIOSCIENCES INC.
Anesthesia, General
1 trial -
TAK-041
NEUROCRINE BIOSCIENCES INC
Stable Schizophrenia
1 trial -
TAK-831
NEUROCRINE BIOSCIENCES INC
Friedreich Ataxia
1 trial -
TD-0903
Theravance Biopharma Ireland Umited
Acute Lung Injury (ALI) Associated With COVID-19
2 trials -
TD-1211
Theravance Biopharma Ireland Umited
Opioid-induced Constipation (OIC)
1 trial -
TD-1211
Theravance Biopharma Ireland Umited
Opioid Induced Constipation
2 trials -
TD-1211
Theravance Biopharma Ireland Umited
Healthy
2 trials -
TD-1792
Theravance Biopharma Ireland Umited
Staphylococcal Skin Infection
1 trial -
TD-4208
Theravance Biopharma Ireland Umited
COPD
2 trials -
TD-4208
Theravance Biopharma Ireland Umited
Chronic Obstructive Pulmonary Disease
1 trial -
TD-5108
Theravance Biopharma Ireland Umited
Chronic Constipation
1 trial -
TD-8236
Theravance Biopharma Ireland Umited
Asthma
2 trials -
TD-9855
Theravance Biopharma Ireland Umited
Neurogenic Orthostatic Hypotension
1 trial -
TD-9855
Theravance Biopharma Ireland Umited
Attention-Deficit/Hyperactivity Disorder
1 trial -
TD-9855 Group 1
Theravance Biopharma Ireland Umited
Fibromyalgia
1 trial -
TG-873870 (Nemonoxacin)
Biotech Pharmaceutical Co.,
Diabetic Foot Infections
1 trial -
THC
BRIGHT MINDS BIOSCIENCES INC.
THC
1 trial -
TKM-080301
Arbutus Biopharma Corp
Hepatocellular Carcinoma
1 trial -
TKM-080301
Arbutus Biopharma Corp
Cancer
1 trial -
TMC207
BRIGHT MINDS BIOSCIENCES INC.
Pulmonary Tuberculosis
1 trial -
TMC207 (J)
BRIGHT MINDS BIOSCIENCES INC.
Pulmonary Tuberculosis
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources